Cargando…
Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer
BACKGROUND: According to previous literatures, plasma thioredoxin reductase (TrxR) level was significantly elevated in various malignant tumors and serve as a potential biomarker for diagnosis and prognostic prediction. However, there is little awareness of the clinical value of plasma TrxR in gynec...
Autores principales: | Zhu, Yinxing, Hu, Yixuan, Shi, Junfeng, Wei, Xiaowei, Song, Yaqi, Tang, Cuiju, Zhang, Wenwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331782/ https://www.ncbi.nlm.nih.gov/pubmed/37365925 http://dx.doi.org/10.1177/15330338231184995 |
Ejemplares similares
-
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2019) -
Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2020) -
Thioredoxin Reductase and its Inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2014) -
Biomarkers of Adverse Response to Mercury: Histopathology versus Thioredoxin Reductase Activity
por: Branco, Vasco, et al.
Publicado: (2012) -
Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
por: Wu, Xuping, et al.
Publicado: (2021)